Catalyst Wire Dossier Catalyst Wire Dossier

Esbriet (pirfenidone)

pirfenidone · Roche
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Esbriet (pirfenidone), covering 2025-08-08 to 2025-10-10. Get the full timeline:

Most recent: Clinical Trial Update: A Study of the Pharmacokinetic Interaction Between Pirfenidone, Nintedanib, and Nalbuphine Extended Release (NAL ER) in Healthy Participants [Phase 1]

See pricing